AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Eset cyber security pro 6.6 300.12/27/2023 ![]() ![]() 229920003013 deoxyribonucleic acid Polymers 0.000 claims abstract description 96.208000005017 Glioblastoma Diseases 0.000 claims abstract description 125.229920000160 (ribonucleotides)n+m Polymers 0.000 claims abstract description 138.108020004707 nucleic acids Proteins 0.000 claims abstract description 192.150000007523 nucleic acids Chemical class 0.000 claims abstract description 197.238000011156 evaluation Methods 0.000 title abstract description 5.238000003745 diagnosis Methods 0.000 title claims abstract description 30.239000010839 body fluid Substances 0.000 title claims abstract description 47.210000001124 Body Fluids Anatomy 0.000 title claims abstract description 48.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US2553608P external-priority Application filed by The General Hospital Corporation filed Critical The General Hospital Corporation Publication of BRPI0907050A2 publication Critical patent/BRPI0907050A2/en Publication of BRPI0907050B1 publication Critical patent/BRPI0907050B1/en Links ![]() Russo Original Assignee The General Hospital Corporation Priority date (The priority date is an assumption and is not a legal conclusion. Methods of diagnosis, monitoring, evaluation and to perform a transfusion of body fluid, and composition of matterÄownload PDF Info Publication number BRPI0907050A2 BRPI0907050A2 BRPI0907050-8A BRPI0907050A BRPI0907050A2 BR PI0907050 A2 BRPI0907050 A2 BR PI0907050A2 BR PI0907050 A BRPI0907050 A BR PI0907050A BR PI0907050 A2 BRPI0907050 A2 BR PI0907050A2 Authority BR Brazil Prior art keywords microvesicles nucleic acid dna rna cells Prior art date Application number BRPI0907050-8A Other languages Portuguese ( pt) ![]()
0 Comments
Read More
Leave a Reply. |